ReviewFrontiers in oncology2021
Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models.
Shanshan Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it
ReviewFrontiers in oncology2021
Shanshan Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.